Full Press Release Details
novel combination of pozelimab and cemdisiran poze cemdi achieved greater control of intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria compared to ravuli.
REGN
novel combination of pozelimab and cemdisiran poze cemdi achieved greater control of intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria compared to ravuli
Key Takeaway: novel combination of pozelimab and cemdisiran poze cemdi achieved greater control of intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria compared to ravuli